Approval · Notice of Compliance 21971 · 2019
HYPERRAB: Notice of Compliance 21971
Issued March 13, 2019
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 21971
- Date
- March 13, 2019
- Company
- Grifols Therapeutics LlcClayton, North Carolina, United States
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Changes to the manufacturing process
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| HYPERRAB | 02486571 | Marketed |
Medicinal ingredients
- RABIES IMMUNOGLOBULIN, HUMAN 300 UNIT per ML